يعرض 1 - 8 نتائج من 8 نتيجة بحث عن '"Cardiovascular Diseases/mortality/prevention & control"', وقت الاستعلام: 1.57s تنقيح النتائج
  1. 1
    دورية أكاديمية

    المصدر: New England Journal of Medicine, 372 (19), 1791-800 (2015)

    العلاقة: urn:issn:0028-4793; urn:issn:1533-4406; https://orbi.uliege.be/handle/2268/248450Test; info:hdl:2268/248450; https://orbi.uliege.be/bitstream/2268/248450/1/nejm%20bonaca%20long%20term%20use%20of%20ticagrelor.pdfTest; scopus-id:2-s2.0-84928944621; info:pmid:25773268

  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية
  4. 4
  5. 5
  6. 6
    دورية أكاديمية

    المساهمون: Institute of Cardiovascular Medicine and Science (ICMS), Royal Brompton Hospital, Robertson Centre for Biostatistics, University of Glasgow, Hôpital Bichat - Claude Bernard, Laboratoire de Recherche Vasculaire Translationnelle (LVTS (UMR_S_1148 / U1148)), Université Paris 13 (UP13)-Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM), Montreal Heart Institute Coordinating Centre (MHICC), Université de Montréal (UdeM), Third Division of Cardiology, Medical University of Silesia (SUM), Department of Cardiology and Laboratory for Technologies of Advanced Therapies Center (DCLTATC), Maria Cecilia Hospital

    المصدر: ISSN: 0028-4793.

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/25176136; hal-01256105; https://hal.univ-brest.fr/hal-01256105Test; PUBMED: 25176136

  7. 7

    المساهمون: Institute of Cardiovascular Medicine and Science (ICMS), Royal Brompton Hospital, Robertson Centre for Biostatistics, University of Glasgow, Hôpital Bichat - Claude Bernard, Laboratoire de Recherche Vasculaire Translationnelle (LVTS (UMR_S_1148 / U1148)), Université Paris Diderot - Paris 7 (UPD7)-Université Paris 13 (UP13)-Institut National de la Santé et de la Recherche Médicale (INSERM), Montreal Heart Institute Coordinating Centre (MHICC), Université de Montréal (UdeM), Third Division of Cardiology, Medical University of Silesia, Department of Cardiology and Laboratory for Technologies of Advanced Therapies Center (DCLTATC), University Hospital of Ferrara and Maria Cecilia Hospital, University of Zurich, Fox, Kim, Medical University of Silesia (SUM)

    المصدر: Fox, K, Ford, I, Steg, P G, Tardif, J-C, Tendera, M, Ferrari, R & Murray, G 2014, ' Ivabradine in Stable Coronary Artery Disease without Clinical Heart Failure ', New England Journal of Medicine, vol. 371, no. 12, pp. 1091-1099 . https://doi.org/10.1056/NEJMoa1406430Test
    New England Journal of Medicine
    New England Journal of Medicine, Massachusetts Medical Society, 2014, 371 (12), pp.1091-9. ⟨10.1056/NEJMoa1406430⟩
    ResearcherID

    مصطلحات موضوعية: Male, drug ther/apy/physiopathology, [SDV]Life Sciences [q-bio], adverse effects/pharmacology/therapeutic use, Angiotensin-Converting Enzyme Inhibitors, 2700 General Medicine, Coronary Artery Disease, Kaplan-Meier Estimate, 030204 cardiovascular system & hematology, Cardiovascular Diseases/mortality/prevention & control, Angina, Coronary artery disease, 0302 clinical medicine, Intention to Treat Analysis Kaplan-Meier Estimate, Heart Rate, Ivabradine, Angiotensin-Converting Enzyme Inhibitors/therapeutic useBenzazepines/adverse effects/pharmacology/*therapeutic use, 030212 general & internal medicine, Myocardial infarction, Stable/drug therapy, Coronary Artery Disease/*drug therapy/physiopathology, General Medicine, Canadian Cardiovascular Society, Middle Aged, mortality/prevention /&/ control, Adrenergic beta-Antagonists/therapeutic use, Stable, 3. Good health, Intention to Treat Analysis, Heart Rate/*drug effects, Cardiovascular Diseases, Combination, Cardiology, Drug Therapy, Combination, Female, medicine.symptom, medicine.drug, Bradycardia, Risk, medicine.medical_specialty, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Adrenergic beta-Antagonists, 610 Medicine & health, therapeutic use, Aged, Angina, drug therapy, Angiotensin-Converting Enzyme Inhibitors, therapeutic use, Benzazepines, adverse effects/pharmacology/therapeutic use, Cardiovascular Diseases, mortality/prevention /&/ control, Coronary Artery Disease, drug ther/apy/physiopathology, Double-Blind Method, Drug Therapy, Combination, Female, Heart Failure, Heart Rate, drug effects, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, therapeutic use, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Middle Aged, Risk, 11171 Cardiocentro Ticino, NO, 03 medical and health sciences, Drug Therapy, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Double-Blind Method, Internal medicine, Heart rate, medicine, Humans, Angina, Stable, Aged, Heart Failure, business.industry, Benzazepines, medicine.disease, therapeutic use, drug effects, Heart failure, Hydroxymethylglutaryl-CoA Reductase Inhibitors, business, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology

    وصف الملف: application/pdf; nejmoa1406430.pdf - application/pdf

  8. 8
    دورية أكاديمية

    المساهمون: LANCELLOTTI, Patrizio

    المصدر: New England Journal of Medicine, 367 (14), 1297-309 (2012)

    العلاقة: urn:issn:0028-4793; urn:issn:1533-4406; https://orbi.uliege.be/handle/2268/151550Test; info:hdl:2268/151550; scopus-id:2-s2.0-84867177857; info:pmid:22920930